|
BeyondSpring Inc. (BYSI) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
BeyondSpring Inc. (BYSI) Bundle
Enhance your investment choices with the BeyondSpring Inc. (BYSI) DCF Calculator! Utilize real financial data from BeyondSpring, adjust growth projections and expenses, and instantly observe the effects on the intrinsic value of BeyondSpring Inc. (BYSI).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .2 | 1.4 | 1.4 | 1.8 | 2.3 | 3.1 | 4.1 | 5.4 | 7.1 |
| Revenue Growth, % | 0 | 0 | 650.56 | 0 | 29.61 | 32.4 | 32.4 | 32.4 | 32.4 | 32.4 |
| EBITDA | -40.2 | -63.7 | -64.5 | -35.0 | -21.5 | -1.4 | -1.8 | -2.4 | -3.2 | -4.3 |
| EBITDA, % | 100 | -35366.11 | -4773.5 | -2587.42 | -1230.15 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .1 | .1 | .1 | 1.1 | .3 | 1.2 | 1.5 | 2.0 | 2.7 | 3.6 |
| Depreciation, % | 100 | 42.78 | 4.52 | 84.68 | 17.25 | 49.84 | 49.84 | 49.84 | 49.84 | 49.84 |
| EBIT | -40.3 | -63.7 | -64.6 | -36.1 | -21.8 | -1.4 | -1.8 | -2.4 | -3.2 | -4.3 |
| EBIT, % | 100 | -35408.89 | -4778.02 | -2672.09 | -1247.4 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 35.9 | 109.5 | 72.4 | 37.3 | 8.0 | 2.3 | 3.1 | 4.1 | 5.4 | 7.1 |
| Total Cash, percent | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .5 | .6 | .8 | 1.1 | 1.4 |
| Account Receivables, % | 100 | 0 | 0 | 0 | 0 | 20 | 20 | 20 | 20 | 20 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .5 | .6 | .8 | 1.1 | 1.4 |
| Inventories, % | 100 | 0 | 0 | 0 | 0 | 20 | 20 | 20 | 20 | 20 |
| Accounts Payable | 2.5 | 2.2 | 1.7 | 1.1 | 1.4 | 2.1 | 2.8 | 3.7 | 5.0 | 6.6 |
| Accounts Payable, % | 100 | 1231.11 | 122.58 | 80.01 | 80.35 | 92.07 | 92.07 | 92.07 | 92.07 | 92.07 |
| Capital Expenditure | .0 | -.1 | -2.8 | .0 | -.1 | -.6 | -.8 | -1.1 | -1.5 | -2.0 |
| Capital Expenditure, % | 100 | -28.89 | -210.51 | -2.52 | -5.71 | -27.42 | -27.42 | -27.42 | -27.42 | -27.42 |
| Tax Rate, % | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 |
| EBITAT | -38.3 | -61.0 | -68.1 | -36.3 | -21.0 | -1.4 | -1.8 | -2.4 | -3.1 | -4.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -35.7 | -61.3 | -71.5 | -35.7 | -20.5 | -1.0 | -.7 | -.9 | -1.3 | -1.7 |
| WACC, % | 5.76 | 5.77 | 5.78 | 5.78 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 | 5.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -2 | |||||||||
| Terminal Value | -45 | |||||||||
| Present Terminal Value | -34 | |||||||||
| Enterprise Value | -39 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -35 | |||||||||
| Diluted Shares Outstanding, MM | 39 | |||||||||
| Equity Value Per Share | -0.89 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real BYSI financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect BeyondSpring Inc.'s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complemented by step-by-step instructions.
Key Features
- 🔍 Real-Life BYSI Financials: Pre-filled historical and projected data for BeyondSpring Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate BeyondSpring's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize BeyondSpring's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring BeyondSpring Inc.’s (BYSI) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with key metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including BeyondSpring Inc.’s (BYSI) intrinsic value.
- Step 5: Make informed investment decisions or create reports based on the outputs.
Why Choose BeyondSpring Inc. (BYSI)?
- Innovative Solutions: We leverage cutting-edge technology to enhance drug development processes.
- Proven Expertise: Our team consists of industry veterans with a track record of success in biopharmaceuticals.
- Commitment to Quality: Rigorous standards ensure the highest quality in our research and development efforts.
- Patient-Centric Approach: Our focus is on improving patient outcomes through advanced therapeutic options.
- Strong Partnerships: Collaborations with leading institutions amplify our capabilities and reach.
Who Should Use This Product?
- Healthcare Professionals: Understand drug development processes and analyze clinical trial data.
- Researchers: Integrate advanced pharmaceutical models into studies or publications.
- Investors: Evaluate your investment strategies and assess valuation metrics for BeyondSpring Inc. (BYSI).
- Market Analysts: Enhance your analyses with a customizable financial model tailored for biotech companies.
- Entrepreneurs: Learn how large biotech firms like BeyondSpring Inc. (BYSI) are evaluated in the market.
What the Template Contains
- Pre-Filled DCF Model: BeyondSpring Inc.'s (BYSI) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate BeyondSpring Inc.'s (BYSI) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.